AI Science Tracker
EN

Longitudinal records supported forecasts of multiple sclerosis progression

Sapienza University of Rome; IRCCS Istituto Neurologico Mediterraneo Neuromed · 20 Mar 2020 · medicine

Discovery

Longitudinal records supported forecasts of multiple sclerosis progression

Source check: Source checked. Not independent scientific confirmation.

Finding: The study used routine records from 1,624 people with multiple sclerosis to forecast transition from relapsing-remitting to secondary-progressive disease at 180, 360 and 720 days. Visit-based models had 70–100% recall but 5–10% precision without confidence filtering; the history model reached 67% recall and 42% precision at 720 days. Few transitions and false positives limit treatment use; the study does not show clinical benefit.

Technology: Recurrent neural network (LSTM); random forest, SVM, KNN and AdaBoost

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The models learned from clinical visits or longitudinal patient history to forecast disease-course transition.
Test and result
A single-center retrospective cohort of 18,574 visits from 1,624 patients. Visit models used patient-wise leave-one-group-out evaluation; the history model used a train/test split because leave-one-group-out training was computationally infeasible.
Limitation / still unknown
No independent, prospective or clinical-impact evaluation is reported unless specified in the tested field.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1371/journal.pone.0230219

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Read the original full text, including author affiliations, Methods and Results; checked the first result-bearing version and active/archive catalog for same-result records..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.